CELLEX SYSTEM

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed with the FDA on 2020-03-10 for CELLEX SYSTEM manufactured by Therakos, Inc. / Mallinckrodt Hospital Products, Inc..

Event Text Entries

[183352079] Pulmonary emboli (pe) was diagnosed in a pt who had received 18 extracorporeal photopheresis (ecp) treatments via the cellex system. Bronchiolitis obliterans syndrome (bos). The pt received is 18th ecp treatment on (b)(6) 2019. The pe event occurred on (b)(6) 2019. The pi reported no relationship. The pt was hospitalized for the event. The pt was initially evaluated in clinic for increased shortness of breath and admitted to the hosp. Ct chest without contrast (b)(6) 2019: postoperative change from bilateral lung transplant, eccentric nonocclusive filling defect within the right main pulmonary artery proximal to the pulmonary artery anastomosis measuring 2. 9 x 1. 6 cm. Findings are consistent with thrombus; however, the chronicity is uncertain and could be acute or chronic; new bilateral groundglass and patchy consolidative opacities most severely affecting the left upper lobe. Findings favor multifocal infection; diffuse mosaic attenuation of the lungs most commonly associated with air trapping / constrictive bronchiolitis; new 4mm right upper lobe nodule may be inflammatory, however recommend 3 month f/u to ensure stability; aortic and coronary artery atherosclerosis. Stable mild dilation of the mid ascending aorta measuring 4 cm. The main pulmonary artery is dilated; pneumobilia which is new from the prior correlate with interval interventions. Treated with heparin drip and changed to oral anticoagulation. The pt received 18 ecp treatments for bronchiolitis obiterons syndrome: (b)(6) 2019, (b)(6) 2019, (b)(6) 2019, (b)(6) 2019. Following the pe event the pt resumed ecp treatments and completed 24 total.
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report NumberMW5093661
MDR Report Key9818142
Date Received2020-03-10
Date of Report2020-03-06
Date of Event2019-06-21
Date Added to Maude2020-03-11
Event Key0
Report Source CodeVoluntary report
Manufacturer LinkN
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Single Use3
Previous Use Code3
Event Type3
Type of Report3

Device Details

Brand NameCELLEX SYSTEM
Generic NameSYSTEM, PHOTOPHERESIS, EXTRACOPOREAL
Product CodeLNR
Date Received2020-03-10
OperatorHEALTH PROFESSIONAL
Device AvailabilityN
Device Eval'ed by MfgrI
Device Sequence No1
Device Event Key0
ManufacturerTHERAKOS, INC. / MALLINCKRODT HOSPITAL PRODUCTS, INC.


Patients

Patient NumberTreatmentOutcomeDate
101. Hospitalization; 2. Other 2020-03-10

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.